Bixiye
QP28-20 Updated Service Type Options for Surgery on Availity Portal
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2551 - 2560 ee natiijooyinka 3289
Bixiye
QP29-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Peanut Allergy
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP30-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP27-20 Coronavirus (COVID-19) Information for Providers
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit®
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP26-20 CMS Decision Memo on Acupuncture for Chronic Low Back Pain
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP24-20 Pharmacy Benefit Update – Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
QP8R1-20 Update: Medical Drug Update for Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Mar 11, 2020
Bixiye
P20-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2020